- Round ID
- FR-00025
- Stage
- Series C
- Round name
- Series C
- Amount
- $226.5M
Dated funding evidence
Apollo Therapeutics
Series C · $226.5M · 2023-09-06
Reported round$226.5MSeries C
- Disclosure date
- 2023-09-06
- Reported currency
- USD
- Companies House
- 13393274
- Evidence sources
- 1
2023-09-06Series C$226.5M
Resolved investor records
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Patient Square Capital
- Other investors
- Rock Springs Capital
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.